Samsung Bioepis has begun direct sales of the low-concentration formulation(40 mg/ml) of its ophthalmic disease treatment, OPUVIZ, in Europe.

Samsung Electronics supplied the world’s first 12-layer HBM4E samples to global customers.

Samsung Electronics reached an agreement on its 2026 wage negotiations with the joint bargaining group of Samsung Electronics labor unions on May 27.

Samsung Electronics (005930) will officially introduce external generative AI services in June for employees in its DX Division.

KOSCOM has formed an exclusive technology alliance with Finger, a fintech specialist, to lead digital financial innovation.

Samsung Electronics(005930) and its labor union failed to reach an agreement in the post-mediation process conducted under the arbitration of the National Labor Relations Commission.

The Samsung family has completed the payment of KRW 12 trillion in inheritance tax on the estate of the late Chairman Lee Kun-hee.

Celltrion has completed its application to the European Medicines Agency(EMA) for approval of ‘Herzuma SC,’ a subcutaneous formulation of the breast cancer treatment Herzuma, thereby securing a new hyaluronidase-based subcutaneous formulation platform.

Samsung SDS supports the Ministry of the Interior and Safety’s OnAI mobile service with its generative AI-based collaboration solution, ‘Brity Works’.

HD Hyundai Heavy Industries has won a 627.1 billion won contract to supply power generation equipment to U.S.